UCLA Integrated Substance Abuse Programs Amity In-Prison Therapeutic Community: Five-Year Outcomes Association of Criminal Justice Research (CA) Sacramento,

Slides:



Advertisements
Similar presentations
Amity In-Prison Therapeutic Community: Preliminary Five-Year Outcomes
Advertisements

Gender Differences in Health Status Among Opiate Users in a 25-Year Follow-up Study Christine Grella & Luz Rodriguez UCLA Integrated Substance Abuse Programs.
Treatment of Substance Involved Offenders in Criminal Justice Settings – Challenges & Outcomes Igor Koutsenok, MD, MS Assistant Professor of Psychiatry,
Abstract People who enter substance abuse treatment under various degrees of legal pressure do at least as well at the end of treatment or at follow-up.
TEMPLATE DESIGN © Limited Health Literacy is Common in Former Prison Inmates Mim Ari, MD 1, Joel M. Hirsh, MD 2, Brenda.
Background: The low retention rates among African Americans in substance abuse treatment (Milligan et al., 2004) combined with the limited number of treatments.
Differences in Characteristics of Heroin Inhalers and Injectors at Admission to Treatment J. C. Maxwell, R. T. Spence, & T. M. Bohman UT Center for Social.
The Catalyst Group, LLC Adolescent Residential Treatment Initiative I Mua Mau Ohana Project Preliminary Findings Richard Kim, Ph.D. 03/03/2005 Funded by.
Conducting Research in Challenging Times: California Parolee Reentry Court Evaluation Association of Criminal Justice Research, California March
Douglas B. Marlowe, J.D., Ph.D. Treatment Research Institute at the University of Pennsylvania TRI science addiction Effective Strategies for Drug-Abusing.
Preliminary Findings: Recovery Center Outcome Study
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse RESEARCH and TREATMENT Provide.
Drug Offender Sentencing Alternative (DOSA): Treatment and Supervision
Re-Entry and Recidivism
MARGUERITE BRYAN, PH.D. CRIMINAL JUSTICE INSTITUTE NOVA SOUTHEASTERN UNIVERSITY FORT LAUDERDALE, FLORIDA ACADEMY OF CRIMINAL JUSTICE SCIENCES ANNUAL CONFERENCE.
Melissa Klein 11/6/ Healthcare for the Homeless Project (HCHP) 1996 HCHP becomes grantee to run community health centers and becomes a FQHC.
ENROLLING JUSTICE INVOLVED POPULATIONS: POLICY IMPLICATIONS LINDSAY NELSON KENTUCKY PRIMARY CARE ASSOCIATION.
Journal Club Alcohol and Health: Current Evidence November–December 2004.
Criminal Justice Drug Abuse Treatment Studies American Society of Criminology November 16, 2011.
1 Mental Health and Co- Occurring Treatment Needs of Individuals in the Criminal Justice System American Psychiatric Association 2007 Annual Meeting May.
Evaluation of the Connecticut Judicial Branch’s Three Court-Mandated Family Violence Programs: FVEP, EXPLORE, and EVOLVE Stephen M. Cox, Ph.D, Professor.
Psychopharmacotherapy in Correctional Institutions Robert P. Schwartz, M.D. Friends Research Institute Supported by NIDA R01 DA (PI: Kinlock)
Evaluating Prison-Based Therapeutic Community Substance Abuse Programs: The California Initiative William M. Burdon, Ph.D. David Farabee, Ph.D. Michael.
UCLA Drug Abuse Research CenterForever Free Evaluation Forever Free Substance Abuse Treatment Program Outcomes Study Michael Prendergast, Ph.D., Principal.
UCLA Integrated Substance Abuse Programs (ISAP). CSAT MTP Project Goals: To study the clinical effectiveness of the Matrix Model To study the clinical.
NIDA Grants: U10DA015831, K24DA022288, U10DA020024, K23DA022297, U10DA Predictors of Outcome in the Multi-Site CTN Prescription Opioid Addiction.
The relationship between substance abuse treatment and self-reported outcomes among offenders with mental health problems and substance use problems Natalie.
Criminal Justice Reform in California Challenges and Opportunities Mia Bird Northern California Grantmakers Annual Conference – From Ideas to Action May.
Medication Adherence, Substance Use and Psychiatric Symptom Severity among Mental Health Jail Diversion Program Clients Elizabeth N. Burris, Evan M. Lowder,
PowerPoint Template ©2009 Texas Christian University, Center for Instructional Services. For Educational Use Only. Content is the property of the presenter.
2 in 5 prison and jail inmates lack a high school diploma or its equivalent. Employment rates and earnings histories of people in prisons and jails are.
Introduction The United States has one of the largest criminal justice populations in the world with over 6.94 million people under the supervision of.
In-Jail Therapeutic Community Drug Treatment: Impact on Rearrest Rates James K. Cunningham, Ph.D. Research and Education on Addiction and Community Health.
METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.
Outcomes of Treatment for Methamphetamine Use: LA County (“Treatment-as-Usual”) M.-L. Brecht UCLA Integrated Substance Abuse Programs CATES 3/30/2004.
Evaluations of CDCR Substance Abuse Programs: Lessons Learned Michael L. Prendergast, Ph.D. Criminal Justice Research Group UCLA Integrated Substance Abuse.
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
North Carolina TASC NC TASC Bridging Systems for Effective Offender Care Management.
CARIBBEAN BASIN AND HISPANIC ADDICTION TECHNOLOGY TRANSFER CENTER Effects of a Two-facet Intervention to Reduce HIV Risk Behaviors Among Hispanic Drug.
Substance Abuse, Medication Adherence, and Criminality among Mentally Ill Parolees David Farabee & Sylvia Sanchez UCLA Integrated Substance Abuse Programs.
Are Incentives Effective in Improving Participation and Outcomes in Treatment for Substance-Abusing Offenders? Michael L. Prendergast, Ph.D. Elizabeth.
1 Therapeutic Community Treatment in Correctional Settings The Call for An Integrated System George De Leon, Ph.D. Center for Therapeutic Community Research.
Drug Abuse Trends in the State of California Presented to: CA Association for Criminal Justice Research March 17, 2005 Presented by: Kiku Annon, MA, WestEd.
Salient Factor Score CTSFS99. What it is How to use it.
EFFICACY OF A STAGE-BASED BEHAVIORAL INTERVENTION TO PROMOTE STI SCREENING IN YOUNG WOMEN: A RANDOMIZED CONTROLLED TRIAL Chacko MR, Wiemann CM, Kozinetz.
Introduction Results and Conclusions On demographic variables, analyses revealed that ATR clients were more likely to be Hispanic and employed, whereas.
Psychosocial Changes Among Special Populations in a Prison-based Therapeutic Community David Farabee, Michael Prendergast, & Jerome Cartier University.
What is randomization and how does it solve the causality problem? 2.3.
Introduction Results Treatment Needs and Treatment Completion as Predictors of Return-to-Prison Following Community Treatment for Substance-Abusing Female.
METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg.
Muskie School of Public Service 2008 Maine Crime and Justice Data Book March, 2009.
Preparing Communities for Re-Entry of Offenders with Mental Illness: The ACTION Approach Presented by: Andradene Lowe & Kris Wilson.
Methamphetamine Use Among Offenders Association for Criminal Justice Research (CA) March 17, 2005 Jerry Cartier / David Farabee / Michael Prendergast University.
Kathryn P. Jett Director California Department of Alcohol and Drug Programs.
Introduction Results and Conclusions Comparisons of psychiatric hospitalization rates in the 12 months prior to and after baseline assessment revealed.
Racial Disparities in Criminal Justice in Wisconsin Pamela Oliver.
Efficacy of a “One-Shot” Computerized, Individualized Intervention to Increase Condom Use and Decrease STDs among Clinic Patients with Main Partners Diane.
Research Issues on Treating Substance-Abusing Offenders Michael L. Prendergast, Ph.D. William M. Burdon, Ph.D. UCLA Integrated Substance Abuse Programs.
BEHAVIORAL FAMILY COUNSELING AND NALTREXONE FOR MALE OPIOID-DEPENDENT PATIENTS William Fals-Stewart, Ph.D. Research Institute on Addictions.
UCLA Integrated Substance Abuse ProgramsForever Free Evaluation Residential Substance Abuse Treatment Programs for Women Laurie Bright, National Institute.
1 Assessment Guided Life Planning: The San Diego SB 618 Prisoner Reentry Experience Criminal Justice Research Division Darlanne Hoctor Mulmat
Changing adolescent substance use and criminal activity in juvenile drug court: Improving outcomes through family-based treatment Gayle Dakof, Craig Henderson,
Recidivism Rates for DCJ Offenders Exiting Residential Treatment June 2007 Kim Pascual Research & Evaluation.
Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.
JAIL AND SHELTER USE IN THE RICHMOND REGION Margot Ackermann, Ph.D. (803) x11.
Approaches to Linking Process and Outcome Data in a Cross-Site Evaluation Laura Elwyn, Ph.D. Kristin Stainbrook, Ph.D. American Evaluation Association.
PURPOSE BACKGROUND RESULTS STUDY DESIGN & METHODS HIV Risk Behaviors Among Male Prisoners Participating in a Randomized Clinical Trial of Methadone Maintenance.
The War on Drugs AKA the War on Blacks and Browns
Beyond the referral Presented by:
Presentation transcript:

UCLA Integrated Substance Abuse Programs Amity In-Prison Therapeutic Community: Five-Year Outcomes Association of Criminal Justice Research (CA) Sacramento, California March 17, 2005

UCLA Integrated Substance Abuse Programs Prendergast, Michael; Hall, Elizabeth; Wexler, Harry; Melnick, Gerald; & Cao, Yan. (2004). Amity prison-based therapeutic community: Five-year outcomes. Prison Journal, 84(1), McCollister, Kathryn; French, Michael; Prendergast, Michael; Hall, Elizabeth; & Sacks, Stan. (2004). Long-term cost effectiveness of addiction treatment for criminal offenders. Justice Quarterly, 21(3), Funding from the National Institute on Drug Abuse and the Robert Wood Johnson Foundation

UCLA Integrated Substance Abuse Programs Aims To assess long-term post-treatment outcomes of a prison-based TC program To determine differential outcomes within selected subgroups To examine factors that contribute to the long-term recovery of those who did not participate in treatment

UCLA Integrated Substance Abuse Programs Aims To conduct secondary analyses of data previously collected To conduct a cost analysis of the prison TC program and the TC continuing care program

UCLA Integrated Substance Abuse Programs Subjects 715 inmates enrolled in or on a waiting list for a prison-based therapeutic community drug treatment program ( ) Randomly assigned to treatment or comparison group Housed in a Level 3 prison in San Diego Those completing treatment were eligible for TC aftercare at Amity Vista upon release

UCLA Integrated Substance Abuse Programs Subjects Male White 37.8%, Hispanic 30.1%, African American 22.4% Average age at follow up: 38 years (range, 26 to 72) Low educational attainment Primarily users of methamphetamine, heroin, and cocaine Violent: 75% had committed assault, kidnapping, rape, or murder Mean arrests (lifetime) at baseline: 27 Mean incarcerations (lifetime) at baseline: 17 Mean years in prison (lifetime) at baseline: 6

UCLA Integrated Substance Abuse Programs Methods Five-year follow-up interviews : 576 completed (80% of original sample) Face-to-face Many interviews were conducted in jails and prisons Modified NDRI follow-up instrument and DARC’s Natural History instrument Urine samples (31% of completed sample) Hair samples (19% of completed sample)

UCLA Integrated Substance Abuse Programs Methods: Follow-up Status

UCLA Integrated Substance Abuse Programs Findings at Years 1, 2, and 3 Calculated from Lowe, Wexler, & Peters (1998), Wexler, De Leon, Kressel, & Peters (1999) Wexler Melnick, Lowe, & Peters (1999).

UCLA Integrated Substance Abuse Programs Outcomes for Intent-to-Treat Sample Variable (% Yes)Control (n=235) Treatment (n=341) p Reincarcerated within 5 years Used drugs heavily in past year Held a job in past year (Chi-square)

UCLA Integrated Substance Abuse Programs Outcomes for Treatment Subgroups Variable (% Yes)Prison TC Drop (n=77) Prison TC Completer (n=159) Vista Drop (n=26) Vista Completer (n=79 ) p Reincarcerated within 5 years <0.001 Used drugs heavily in past year Held a job in past year <0.001 (Chi-square)

UCLA Integrated Substance Abuse Programs Days to 1st Incarceration

UCLA Integrated Substance Abuse Programs Cost Effectiveness Study Condition Treatment CostDays Incarcerated During Follow-up Control (N=235) $1, Prison TC Only (N=236) $3, Prison TC + Vista (N=105) $15, All Amity Participants (N=341) $7,041544

UCLA Integrated Substance Abuse Programs Cost Effectiveness Cost-Effectiveness Comparison Incremental Treatment Cost Incremental Days Incarcerated Incremental Cost Effectiveness Ratio Ctrl vs. Prison TC Only$1, N/A Ctrl vs. Prison TC + Vista $12,780287$45 Ctrl vs. All Amity Participants $5,31181$65 Prison TC Only vs. Prison TC + Vista $11,969291$41

UCLA Integrated Substance Abuse Programs Summary After five years, reincarceration was high, but Amity participants were significantly less likely to have been returned to prison than comparison subjects. No difference between treatment and comparison groups in drug use and employment. Among treatment subgroups, those who completed Vista TC aftercare performed significantly better on reincarceration and employment measures, but not drug use. Prison treatment plus community treatment is a cost-effective policy for reducing reincarceration.

UCLA Integrated Substance Abuse Programs Thank You Questions? ISAP website: uclaisap.org